The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereotactic radiotherapy (SBRT).
Study Type
OBSERVATIONAL
Enrollment
87
ICO
Nantes, Saint Herblain, France
CHRU de Brest
Brest, France
Centre Eugènes Marquis
Rennes, France
CHU de Tours
Tours, France
Local Recurrence
accuracy
Time frame: Time-to-Event measures up to 5 years
Cancer specific survival
accuracy
Time frame: Time-to-Event measures up to 5 years
Distant metastasis free survival
accuracy
Time frame: Time-to-Event measures up to 5 years
Recurrence free survival
accuracy
Time frame: Time-to-Event measures up to 5 years
Overall survival
accuracy
Time frame: Time-to-Event measures up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.